Professional Documents
Culture Documents
Background
The four drugs furazoidone, furaltadone, nitrofurazone and introfurantoin are veterinary drugs that belong to family of nitrofuran antibiotics Widely used for the treatment of gastrointestinal infections in cattle, pigs and poultry The European Union (EU) banned the use of nitrofuran antibiotics in food-producing animals by listing them in Annex of Council Regulation 2377/90 The EU set a Minimum Required Performance Limit (MRPL) of 1 ug/kg that laboratories should at least detect and confirm
Group/LC/MS Food Safety Applications July, 2006
COMMISSION DECISION of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (2002/657/EC)
2002/657/EC
Sets criteria for screening (< 5 % error) Sets criteria for confirmation For LC/MS
MS Points for confirmation MS ratio of at least two ions Retention time tolerance
EU Regulations -Nitrofurans
COMMISSION DECISION of 13 March 2003 amending Decision 2002/657/EC as regards the setting of minimum required performance limits (MRPLs) for certain residues in food of animal origin (2003/181/EC)
Nitrofuran metabolites: furazolidone Poultry meat furaltadone 1 g/kg for all Aquaculture products nitrofurantoin nitrofurazone
NH O
H2N
O N O
Furaltadone
AMOZ
NPAMOZ
HPLC Parameters
HPLC system Column Injection Volumn Flow rate Mobile phase Gradient
: Agilent 1100 series : C18, 2.1150, 5 m : 50 L : 0.3 mL/min : 40 : A-0.1% Formic acid; B-Acetonitrile
Time 0 10 12 12.01 17 17.01 22 A 90 50 40 5 5 90 90 B 10 50 60 95 95 10 10
Group/LC/MS Food Safety Applications July, 2006
Temp
MS Parameters
MS system Ion source Polarity Nebulizer gas Ion spray voltage Resolution Scan mode Conditions of MRM
: Agilent 6410 LC/MS/MS : ESI : Positive : Nitrogen : 4000V : Q1 (unit) Q3 (unit) : Multiple Reaction Monitoring (MRM)
CE 5V
CE 10V
134.2
149.1
166.2
103.8
119.0
209.1
100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300
Time 0
Compound AMOZ
Dwell (ms) 150 150 150 150 150 150 150 150
Fragmentor (V) 92 92 92 92 92 92 92 92
SC
209.1 209.1
9.95
AH
249.1 249.1
10.8
AOZ
236.0 236.0
, 262.1 Ratio=24.0
}
Acquisition Time (min)
20 % Tolerance
R2=0.99985
AOZ
34
AMOZ
SC AH
10
11
12
13
14
15
16
17
4.513
4.592
+ MRM MRM (236.0 -> 104.3) Quan_Qualify_100ppt_2.d Smooth (1) x10 2 4 1.1 1 0.9 0.8 0.7 0.6 0.5 11 11.5 11.767 12 12.5 13 13.5 14 14.5 15 11.197
15.5
16
16.5
17
17.5
18
18.5
19
19.5
20
20.5
21
21.5
22
S/N=6
S/N=4
10
11
12
13
14
15
16
17
18
19
20
21
22
Blank
A b u n d a n c e v s . A c q u i s i t i o n T i me ( mi n )
10
11
12
13
14
15
16
17
18
19
20
21
22
+ M R M M R M (2 4 9 .1 - > 1 3 4 .2 ) N F _ M R M s p ik e 1 0 0 p p t_ 2 .d S m o o th (1 ) x1 0 2 3 .8 3 .6 3 .4 3 .2 3 2 .8 2 .6 2 .4 2 .2 2 1 .8 1 .6 1 .4 1 .2 1 0 .8 0 .6 1 2 3 4 5 6 7 8 1 0 .0 9 3 1 1 2 2 3
3 4
AOZ
AMOZ SC AH
10 11 12 13 14 15
Spike
A b u n d a n c e v s . A c q u i s i t i o n T i me ( mi n )
16
17
18
19
20
21
22
Supernatant
(acetonitrile phase)
PPt
Add 20ml acetonitrile filter
Supernatant
35ml water, 30ml dichloromethane
Collect dichloromethane phase, add 20ml dichloromethane in upper layer Concentration LC/MS/MS
Group/LC/MS Food Safety Applications July, 2006
HPLC Parameters
HPLC system Column Injection Volumn Flow rate Mobile phase Gradient
: Agilent 1100 series : C18, 2.1150, 5 m : 10 L : 0.3 mL/min : A-10mmol NH4Ac (pH=4.5); B-Acetonitrile
Time 0 1 2 8 8.01 13 A 70 50 5 5 70 70 B 30 50 95 95 30 30
Group/LC/MS Food Safety Applications July, 2006
MS Parameters
MS system Ion source Polarity Nebulizer gas Ion spray voltage Resolution Scan mode Conditions of MRM
: Agilent 6410 LC/MS/MS : ESI : Positive : Nitrogen : 4000V : Q1 (unit) Q3 (unit) : Multiple Reaction Monitoring (MRM)
x10 7 5 4 3 2 1
70V
+ EIC(329.4, 331.4 m/z) Scan optimizing FRG90_4.d
x10 7 5 4 3 2 1
90V
+ EIC(329.4, 331.4 m/z) Scan optimizing FRG100_5.d
x10 7 6 5 4 3 2 1
110V
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 11.5 12
CE 20V
2 1.5 1 0.5 0 193.1 + Product Ion (5.549 min) (329.3 -> **) optimizing MS2_FRG100_CE30_3.d 329.3 208.3 236.9 268.4 284.3 313.5
N
x10 5
2 1.8
-dimethylaniline1.6
1.4
CE 30V
313.4 208.2 164.6 134.3 + Product Ion (5.549 min) (329.3 -> **) optimizing MS2_FRG100_CE40_4.d 313.3 192.8 217.4 237.2 251.4 270.3 285.3 298.9
m/z 208
1.2 1 0.8 0.6 0.4 0.2 0 x10 5 1.2 1 0.8 0.6 0.4 165.3 0.2 0 50 60 70 80 91.5 90 100 110 120 130 140 150 160 170 117.9 134.1 179.8 180 192.1 190 202.0 200 210 221.0 220 230 240 241.4 251.4 250 260 270.3 208.2
CE 40V
329.4 298.9 280 290 300 310 320 330 340 35
284.2
270
Time
Compound
Precursor
Product
329.3 329.3
40 40 40 40
40 40 30 30
331.3 331.3
R2=0.9995
R2=0.9994
LMG
MG
5.440
5.5
6.5
7.5
LMG
MG
Blank
A b u n d a n c e v s . A c q u i s i t i o n T i me ( mi n )
5 .5
6 .5
7 .5
8 .5
9 .5
10
1 0 .5
11
1 1 .5
12
+ M R M M R M (3 2 9 .3 - > 3 1 3 .3 ) S p ik e 1 p p b _ 1 .d x1 0
3
LMG Spike
2
1 2
3 .6 3 .4 3 .2 3 2 .8 2 .6 2 .4 2 .2 2 1 .8 1 .6 1 .4 1 .2 1 0 .8 0 .6 0 .4 0 .2 0 0 .5 1 1 .5 2 2 .5 3 3 .5 4 4 .5 5 5 .5 6 6 .5 7 7 .5 8 8 .5 9 9 .5
MG
A b u n d a n c e v s . A c q u i s i t i o n T i me ( mi n )
10
1 0 .5
11
1 1 .5
Blank
A b u n d a n c e v s . A c q u i s i t i o n T i me ( mi n )
5 .5
6 .5
7 .5
8 .5
9 .5
10
1 0 .5
11
1 1 .5
12
+ M R M M R M (3 3 1 .3 - > 2 3 9 .2 ) S p ik e 1 0 0 p p t_ 1 .d x1 0 2 1 .7 1 .6 1 .5 1 .4 1 .3 1 .2 1 .1 1 0 .9 0 .8 0 .7 0 .6 0 .5 0 .4 0 .3 0 .2 0 .1 0 0 .5 1 1 .5 2 2 .5 3 3 .5 4 4 .5 5 1
MG
LMG
2
1 2
Spike
A b u n d a n c e v s . A c q u i s i t i o n T i me ( mi n )
5 .5
6 .5
7 .5
8 .5
9 .5
10
1 0 .5
11
1 1 .5
12
Compounds
Concentration (ng/mL)
0.1 0.1